sales@scalarmarketresearch.com |  +1-800-213-5170  (U.S./ Canada Toll-free) |  REGISTER |  SIGN IN

Home >> Reports >> cancer biomarkers market

report

Cancer Biomarkers Market, by Types (Lung, Breast, Cervical, Prostate, Colorectal), Biomarker Types (Genetic, Protein), Applications (Diagnostics, Prognostics, Drug Discovery, Risk Management) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC180 November 2016 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the cancer biomarkers market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the cancer biomarkers market. The scope of this report covers the cancer biomarkers market by its major segments, which include types, biomarker types, applications, and the major geographic regions.

KEY BENEFITS OF THE REPORT

  • In-depth analysis of the market segments that will showcase the greatest growth potential
  • Information about the technological advancements influencing the growth of the global market
  • Extensive analysis of the key players dominating the competitive landscape of this market

KEY PREMIUM INDUSTRY INSIGHTS

  • The growth in the incidences of cancer is one of the primary drivers for the cancer biomarkers market.
  • Furthermore, the rising healthcare spending across the world has expanded and improved the access to quality healthcare, which is driving the global market.
  • The increasing demand for personalized medicines for cancer treatments will aid the growth of the cancer biomarkers market.
  • On the other hand, the requirement of huge investments in research, validation of new cancer biomarkers, stringent regulatory norms, and inadequate reimbursement policies may restrain the market growth.

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s cancer biomarkers market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

MARKET SEGMENTATION

This report analyzes the cancer biomarkers market by the following segments:

  • Cancer Biomarkers Market, by Types
    • Lung Cancer
    • Breast Cancer
    • Cervical Cancer
    • Prostate Cancer
    • Colorectal Cancer
    • Other Types
  • Cancer Biomarkers Market, by Biomarker Types
    • Genetic Biomarker
    • Protein Biomarker
  • Cancer Biomarkers Market, by Applications
    • Diagnostics
    • Prognostics
    • Drug Discovery
    • Risk Management
    • Other Applications

KEY MARKET PLAYERS

Key players in the cancer biomarkers market include:

  • Abbott Laboratories
  • F. Hoffmann-La Roche AG
  • Agilent Technologies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Merck & Co. Inc.
  • Qiagen N.V.
  • Becton, Dickinson and Company
  • Hologic, Inc.       
  • Ambrilia Biopharma Inc.

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • REST OF THE WORLD
    • Latin America
    • Middle East & Africa

Cancer Biomarkers Market

TRENDING RELATED REPORT

Biosimilars Market, by Product Types (Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Recombinant Peptides), Applications (Oncology, Blood Disorders, Infectious Diseases, Autoimmune Diseases, and Others) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Market Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Technology Roadmap
    3. Ecosystem Analysis
  5. CANCER BIOMARKERS MARKET, BY TYPES
    1. Segment Share
    2. By Types
      1. Lung Cancer
      2. Breast Cancer
      3. Cervical Cancer
      4. Prostate Cancer
      5. Colorectal Cancer
      6. Other Types
  6. CANCER BIOMARKERS MARKET, BY BIOMARKER TYPES
    1. Segment Share
    2. By Biomarker Types
      1. Genetic Biomarker
      2. Protein Biomarker
  7. CANCER BIOMARKERS MARKET, BY APPLICATIONS
    1. Segment Share
    2. By Applications
      1. Diagnostics
      2. Prognostics
      3. Drug Discovery
      4. Risk Management
      5. Other Applications
  8. CANCER BIOMARKERS MARKET, BY GEOGRAPHY
    1. North America
      1. By Regions
        1. U.S.
        2. Rest of North America
      2. By Types
      3. By Biomarker Types
      4. By Applications
    2. Europe
      1. By Regions
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Types
      3. By Biomarker Types
      4. By Applications
    3. Asia-Pacific
      1. By Regions
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Types
      3. By Biomarker Types
      4. By Applications
    4. Rest of the World
      1. By Regions
        1. Latin America
        2. Middle East & Africa
      2. By Types
      3. By Biomarker Types
      4. By Applications
  9. COMPETITIVE LANDSCAPE
  10. KEY MARKET PLAYERS
    1. Abbott Laboratories
      1. Overview
      2. Key Strategies
      3. Key Developments
    2. F.Hoffmann-La Roche AG
      1. Overview
      2. Key Strategies
      3. Key Developments
    3. Agilent Technologies
      1. Overview
      2. Key Strategies
      3. Key Developments
    4. Thermo Fisher Scientific Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    5. Illumina, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    6. Merck & Co. Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
    7. QIAGEN
      1. Overview
      2. Key Strategies
      3. Key Developments
    8. Becton, Dickinson, and Company
      1. Overview
      2. Key Strategies
      3. Key Developments
    9. Hologic, Inc.
      1. Overview
      2. Key Strategies
      3. Key Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170

EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

Unparalleled Expertise

Our industry experts hold inimitable know-how across wide range of industry verticals

Assured Quality

We deliver high-quality, real-time and data-driven industry insights to our clients

24x7 Analyst Support

We offer pre-purchase and post-purchase support from our industry experts

Privacy & Security

All your personal information and confidential details are safe and secure with us